Are Growth Phases Exclusive to Cutaneous Melanoma?

Overview

Journal J Clin Pathol

Specialty Pathology

Date 2004 Apr 29

PMID 15113872

Citations 4

Authors

C Urso

Affiliations

Soon will be listed here.

Citing Articles

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance.

Kharouf N, Flanagan T, Alamodi A, Al Hmada Y, Hassan S, Shalaby H Cells. 2024; 13(3.

PMID: 38334632 PMC: 10854812. DOI: 10.3390/cells13030240.

Tumor-infiltrating lymphocytes as a prognostic and predictive factor for Melanoma.

Vargas G, Shafique N, Xu X, Karakousis G Expert Rev Mol Diagn. 2024; 24(4):299-310.

PMID: 38314660 PMC: 11134288. DOI: 10.1080/14737159.2024.2312102.

MicroRNA as a Diagnostic Tool, Therapeutic Target and Potential Biomarker in Cutaneous Malignant Melanoma Detection-Narrative Review.

Poniewierska-Baran A, Zadroga L, Danilyan E, Malkowska P, Niedzwiedzka-Rystwej P, Pawlik A Int J Mol Sci. 2023; 24(6).

PMID: 36982460 PMC: 10048937. DOI: 10.3390/ijms24065386.

Overcoming Immune Evasion in Melanoma.

Eddy K, Chen S Int J Mol Sci. 2020; 21(23).

PMID: 33256089 PMC: 7730443. DOI: 10.3390/ijms21238984.

References

Elder D, Guerry 4th D, Epstein M, Zehngebot L, Lusk E, VAN HORN M . Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol. 1984; 6 Suppl:55-61. View

Urso C, Bondi R, Paglierani M, Salvadori A, Anichini C, Giannini A . Carcinomas of sweat glands: report of 60 cases. Arch Pathol Lab Med. 2001; 125(4):498-505. DOI: 10.5858/2001-125-0498-COSG. View